These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31642960)
41. Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat. Mills C; McMackin M; Jaffe R; Yu J; Zininberg E; Slee D; Gogas K; Bradbury M Neuroscience; 2008 Sep; 156(1):165-74. PubMed ID: 18706981 [TBL] [Abstract][Full Text] [Related]
42. Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'. Levinson DF; Simpson GM Arch Gen Psychiatry; 1986 Sep; 43(9):839-48. PubMed ID: 2875701 [TBL] [Abstract][Full Text] [Related]
43. Antipsychotic Medication-Induced Hyperthermia Leading to Cerebrovascular Accident: A Case Report. Best K; Tran DH; Bulte C; Verceles AC; Michael MB Cureus; 2021 Oct; 13(10):e18651. PubMed ID: 34659926 [TBL] [Abstract][Full Text] [Related]
44. [Heatstroke among psychiatric patients under neuroleptic therapy. Apropos of 2 fatal cases]. Ducrot P; Jouan JC; Sala JP; Mathon J Ann Anesthesiol Fr; 1979; 20(8):709-16. PubMed ID: 44988 [TBL] [Abstract][Full Text] [Related]
48. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Lee KC; Finley PR; Alldredge BK Expert Opin Drug Saf; 2003 May; 2(3):233-47. PubMed ID: 12904103 [TBL] [Abstract][Full Text] [Related]
49. Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications. Aggarwal NK; Sernyak MJ; Rosenheck RA J Clin Psychopharmacol; 2012 Jun; 32(3):323-8. PubMed ID: 22544006 [TBL] [Abstract][Full Text] [Related]
50. Functional hyperthermia due to central dopaminergic impairment. Di Rosa AE; Morgante L; Coraci MA; Crisafulli A; Cacciola G; Di Stefano G; Meduri M; Di Perri R Funct Neurol; 1988; 3(2):211-5. PubMed ID: 2900182 [TBL] [Abstract][Full Text] [Related]
51. [Malignant hyperthermia syndrome in the intensive care unit : Differential diagnosis and acute measures]. Grander W Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):407-16. PubMed ID: 27272514 [TBL] [Abstract][Full Text] [Related]
52. Attitudes and behaviour towards psychotropic drug prescribing in Swedish primary care: a questionnaire study. Svensson SA; Hedenrud TM; Wallerstedt SM BMC Fam Pract; 2019 Jan; 20(1):4. PubMed ID: 30611211 [TBL] [Abstract][Full Text] [Related]
53. Pathogenesis and treatment of neuroleptic malignant syndrome. Ebadi M; Pfeiffer RF; Murrin LC Gen Pharmacol; 1990; 21(4):367-86. PubMed ID: 1974219 [TBL] [Abstract][Full Text] [Related]
54. Restoration of thermoregulation after exercise. Kenny GP; McGinn R J Appl Physiol (1985); 2017 Apr; 122(4):933-944. PubMed ID: 27881668 [TBL] [Abstract][Full Text] [Related]
55. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555 [TBL] [Abstract][Full Text] [Related]
56. Diagnosis and treatment of drug-induced hyperthermia. Musselman ME; Saely S Am J Health Syst Pharm; 2013 Jan; 70(1):34-42. PubMed ID: 23261898 [TBL] [Abstract][Full Text] [Related]
58. Trends in psychotropic use in Saskatchewan from 1983 to 2007. Meng X; D'Arcy C; Tempier R Can J Psychiatry; 2013 Jul; 58(7):426-31. PubMed ID: 23870725 [TBL] [Abstract][Full Text] [Related]
59. Body temperature regulation and drugs of abuse. Sprague JE; Riley CL; Mills EM Handb Clin Neurol; 2018; 157():623-633. PubMed ID: 30459028 [TBL] [Abstract][Full Text] [Related]
60. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. Gobert M; D'hoore W Int J Geriatr Psychiatry; 2005 Aug; 20(8):712-21. PubMed ID: 16035123 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]